Painreform is trading 8.36% lower at $0.70, consistent with weaker broad-market sentiment.
- The Nasdaq Composite is down 1.63% and the S&P 500 is down 0.84%, suggesting a possible risk-off backdrop, not a confirmed company-specific catalyst.
- No October 22 company-specific announcement was identified; its investor-relations page lists releases dated September 16, September 9, and September 3.
- Current volume information was unavailable.